Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
MLAB

Market Cap: $676.37M

MI

Mesa Laboratories, Inc.

MLAB

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin65.99%

EBITDA Margin16.25%

EBIT Margin7.05%

Pre-tax Margin3.75%

Net Profit Margin1.92%

Earnings Yield0.70%

Valuation Multiples

Price / Book3.62

Price / Sales2.71

Price / Earnings140.55

PEG-0.38

Forward PEG9.16

EV / Sales2.99

EV / EBITDA18.41

EV / Operating Cash Flow13.42

EV / Free Cash Flow13.31

Price / Free Cash Flow12.05

Price / Operating Cash Flow12.28

Cash Flow & Capital

Free Cash Flow / Share$9.92

Operating Cash Flow / Share$9.84

Free Cash Flow Yield8.30%

Capex / Revenue0.18%

Capex / Operating Cash Flow0.81%

Capex / Depreciation-1.44

Stock Compensation / Revenue-0.61%

Dividend Payout Ratio73.63%

Dividend Yield0.53%

Liquidity & Leverage

Current Ratio2.07

Quick Ratio1.52

Cash Ratio0.62

Debt / Assets0.24

Debt / Capital0.35

Debt / Equity0.54

Long-Term Debt / Capital0.33

Debt / Market Cap14.60%

Net Debt / EBITDA1.74

Solvency Ratio0.12

Financial Leverage2.22

Efficiency & Working Capital

Asset Turnover0.60

Fixed Asset Turnover8.30

Inventory Turnover3.12

Receivables Turnover7.26

Payables Turnover11.39

Days Sales Outstanding50.29

Days Inventory Outstanding117.01

Days Payables Outstanding32.05

Operating Cycle167.3

Cash Conversion Cycle135.25

Working Capital Turnover5.12

Returns & Quality

Return on Equity2.59%

Return on Assets1.14%

Return on Invested Capital3.05%

ROCE6.08%

Return on Tangible Assets3.10%

Operating Return on Assets5.31%

Income Quality-29.12

Tax Burden0.51

Interest Burden0.53

Balance Sheet & Intrinsic Metrics

Enterprise Value$747.03M

Invested Capital$347.73M

Working Capital$53.2M

Tangible Asset Value$-75.68M

Net Current Asset Value$-127.62M

Graham Number$25.24

Graham Net-Net-$28.35

Book Value / Share$33.37

Tangible Book Value / Share-$13.38

Cash / Share$5.43

Financial Health Scores

Piotroski Score7

Altman Z-Score2.03

Revenue$249.73M

EBIT$17.62M

Market Cap$676.6M

Working Capital$53.2M

Retained Earnings$-183.8M

Total Assets$419.22M

Total Liabilities$230.46M